According to the recent study published in the Journal of American Medical Association, a new topical treatment for atopic dermatitis (AD) has been shown as a safe, effective, and ...

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of race, ethnicity, and Fitzpatrick skin typeZORYVE was safe ...

在其他近期新闻中，Arcutis Biotherapeutics报告2024年第二季度业绩强劲，净收入达到30.9百万美元，较第一季度净产品收入增长43%。这一增长主要由其皮肤病产品（包括Zoryve乳膏和泡沫）的处方量显著增长推动。Mizuho Securities和TD ...

Roflumilast cream 0.15% was well tolerated and significantly improved symptoms in adults and children with mild to moderate atopic dermatitis (AD) in two phase 3 trials. The two phase 3 randomized ...

Experts at the Skin of Color Update today in New York City highlighted recent FDA-approved dermatological treatments and ...

(RTTNews) - Arcutis Biotherapeutics, Inc. (ARQT), Wednesday announced positive results from the INTEGUMENT-open label extension long-term study of once-daily roflumilast cream 0.05% in the ...

Key Laboratory of Orogenic Belts and Crustal Evolution, Department of Geology, Peking University, Beijing, China School of Geoscience and Surveying Engineering, China University of Mining and ...

The integumentary system comprises your skin, hair, nails, and glands. The system acts as a physical barrier between the outside world and what's inside your body. In doing so, the integumentary ...